Samsung Biologics publishes prospectus for PolyPeptide public tender offer

Direct subsidiary Samsung Peptide AG acting as formal offeror of the public tender offer Publication of offer prospectus follows pre-announcement on July 20, 2026 Largest individual shareholder committed to tender all of its PolyPeptide shares into offer Main offer period expected to last...